Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan;84(1):e23-e25.
doi: 10.1016/j.jinf.2021.10.021. Epub 2021 Oct 30.

Prevalence of SARS-CoV-2 antibodies after one-year follow up among workers in a research institute in Japan

Akihiko Nishikimi  1 , Ken Watanabe  2 , Atsushi Watanabe  3 , Mikako Yasuoka  4 , Ryota Watanabe  4 , Hironori Oshima  5 , Yuichi Kitagawa  6 , Haruhiko Tokuda  7 , Shumpei Niida  8 , Masayo Kojima  4
Affiliations

Prevalence of SARS-CoV-2 antibodies after one-year follow up among workers in a research institute in Japan

Akihiko Nishikimi et al. J Infect. 2022 Jan.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declarations of Competing Interest None

Figures

Fig 1
Fig. 1
Transition of the level of anti-N protein in seropositive participants. Index for each test was plotted for the participants who were positive in the 2020 survey. The dots and lines with the same color indicate the same individuals. Positive values are indicated in dotted lines.
See this image and copyright information in PMC

References

    1. Furuse Y., Ko Y.K., Saito M., Shobugawa Y., Jindai K., Saito T., et al. Epidemiology of COVID-19 outbreak in Japan, January-March 2020. Jpn J Infect Dis. 2020;73:391–393. - PubMed
    1. Karako K., Song P., Chen Y., Tang W., Kokudo N. Overview of the characteristics of and responses to the three waves of COVID-19 in Japan during 2020-2021. BioSci Trends. 2021;15:1–8. - PubMed
    1. Yamamoto S., Tanaka A., Oshiro Y., Ishii M., Ishiwari H., Konishi M., et al. Seroprevalence of SARS-CoV-2 antibodies in a national hospital and affiliated facility after the second epidemic wave of Japan. J Infect. 2021;88:237–279. - PMC - PubMed
    1. Nishikimi A., Kojima M., Watanabe K., Watanabe A., Yasuoka M., Oshima H., et al. Seroprevalence of antibodies against SARS-CoV-2 among workers in a national research institute and hospital in Central Japan. GHM Open. 2021;1:40–42.
    1. Ministry of Health and Labour J. Results of a survey on SARS-CoV-2 antibody in the general population in Japan as of December 2020. 2020 [cited 2021 March 15]; Available from: https://www.mhlw.go.jp/content/000734482.pdf .

Publication types

Substances